---
title: "Belite Bio Announces Oral Presentations at Two Upcoming Medical Conferences"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291795109.md"
description: "Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage drug development company, revealed that its data will be featured at the 63rd Annual Symposium of ISCEV in Sydney, Australia from July 6-11, 2026, and at the ASRS 2026 Annual Meeting in Montréal, Canada from July 15-18, 2026. The company focuses on innovative therapeutics for degenerative retinal diseases with substantial unmet medical needs."
datetime: "2026-07-06T11:02:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291795109.md)
  - [en](https://longbridge.com/en/news/291795109.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291795109.md)
generator: "portal-rs"
---

# Belite Bio Announces Oral Presentations at Two Upcoming Medical Conferences

Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage drug development company, revealed that its data will be featured at the 63rd Annual Symposium of ISCEV in Sydney, Australia from July 6-11, 2026, and at the ASRS 2026 Annual Meeting in Montréal, Canada from July 15-18, 2026. The company focuses on innovative therapeutics for degenerative retinal diseases with substantial unmet medical needs.

### Related Stocks

- [BLTE.US](https://longbridge.com/en/quote/BLTE.US.md)

## Related News & Research

- [BLTE: Tinlarebant slowed Stargardt lesion growth and is on track for U.S. launch in March 2027](https://longbridge.com/en/news/297809717.md)
- [Coya Therapeutics posts September 2026 investor presentation on neurodegeneration pipeline](https://longbridge.com/en/news/297669200.md)
- [FibroBiologics wins new US patent for degenerative disc disease treatment using fibroblast conditioned media](https://longbridge.com/en/news/297652903.md)
- [Number of shares and votes in BioArctic AB (publ) as of August 31, 2026](https://longbridge.com/en/news/297542152.md)
- [14:52 ETAPhA Foundation Announces 2026 Pinnacle Award Recipients](https://longbridge.com/en/news/297361032.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**